Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • All Multimedia

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Accessories
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High-Tech Security
      • Internet Technology
      • Nanotechnology
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Projections or Forecasts
      • Financing Agreements
      • Insurance
      • Investment Options
      • Joint Ventures
      • Mutual Funds
      • Offerings
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing/marketing agreements
      • New Products & Services
      • Obituary
      • Outsourcing Businesses
      • Overseas Real Estate (Non-US)
      • Personnel Announcements
      • Residential Real Estate
      • Small-Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Accessories
      • Computer Electronics
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Design Automation
      • Financial Technology
      • Mobile Devices/Apps
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Natural Gas Utilities
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Computer Accessories
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Computer Accessories
      • Computer Networks
      • Mobile Devices/Apps
      • Telecommunications
      • Telecommunications Carriers & Services
      • Telecommunications Equipment
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wine & Spirits
      • Beverages
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infectious Disease Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental Products & Services
      • European Government
      • Natural Disasters
      • Not-for-Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Children-related news
      • Disabled Persons
      • Diversity, Equity & Inclusion
      • Hispanic-oriented news
      • LGBTQ+
      • Religion
      • Senior Citizens
      • Veterans
      • Women-Related news
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring Home
  • Send a Release
    • Chat

    • ALL CONTACT INFO
    • Contact Us


  • News Releases
  • Send a Release
  • Data Privacy
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • News Releases
  • Send a Release
  • Data Privacy
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • News Releases
  • Send a Release
  • Data Privacy
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • News Releases
  • Send a Release
  • Data Privacy

PARSOL® Shield Diluluskan oleh FDA, dsm-firmenich Buka Era Baharu Perlindungan Matahari di AS

  • APAC - English
  • Vietnam - Vietnamese
  • APAC - English
  • India - English

News provided by

dsm-firmenich

01 Sep, 2026, 08:00 CST

Share this article

Share toX

Share this article

Share toX

KAISERAUGST, Switzerland dan MAASTRICHT, Belanda, 1 September 2026 /PRNewswire/ -- dsm-firmenich, peneraju inovasi dalam bidang pemakanan, kesihatan dan kecantikan, dengan bangganya mengumumkan kelulusan FDA bagi PARSOL® Shield (bemotrizinol, BEMT) untuk pasaran Amerika Syarikat, menjadikannya bahan aktif pelindung matahari baharu pertama yang diluluskan di Amerika Syarikat dalam tempoh lebih 25 tahun di bawah garis panduan penilaian GRASE (Generally Recognized as Safe and Effective) dan MUsT (Maximal Usage Trial) yang dimodenkan.

Continue Reading

Kelulusan itu menandakan pencapaian penting bagi inovasi pelindung matahari dan kesihatan kulit awam di Amerika Syarikat, membantu memperluas akses kepada perlindungan UV generasi akan datang, di samping membuka peluang baharu kepada pakar formulasi di seluruh industri.

"Kelulusan PARSOL® Shield merupakan satu langkah penting ke hadapan bukan sahaja untuk dsm-firmenich, malah untuk masa depan perlindungan matahari di AS," kata Parand Salmassinia, Presiden Beauty & Care di dsm-firmenich. "Pencapaian ini mencerminkan kepimpinan saintifik selama bertahun-tahun, kerjasama dengan pihak kawal selia serta komitmen untuk membawa inovasi yang bermakna kepada pengguna."

Kajian klinikal melibatkan PARSOL® Shield (BEMT) dengan penyertaan hampir 500 individu yang mewakili kepelbagaian penduduk AS menunjukkan keberkesanan perlindungan UV yang cemerlang, tahap toleransi yang sangat baik serta profil keselamatan yang sangat baik.

PARSOL® Shield (BEMT) membantu memenuhi keperluan sebenar pengguna, daripada mengurangkan risiko kanser kulit kepada melindungi kulit daripada kerosakan jangka panjang akibat UV dan penuaan pramatang akibat cahaya matahari. Bagi pakar formulasi, bahan aktif itu membolehkan penghasilan pelindung matahari dengan tekstur halus dan ringan, di samping menawarkan kestabilan terhadap cahaya yang tinggi serta fleksibiliti formulasi.

"Kelulusan ini menandakan satu pencapaian penting bagi perlindungan matahari di Amerika Syarikat," kata Dr. Jochen Klock, Pengarah Hal Ehwal Kawal Seliaan Global, Beauty & Care di dsm-firmenich. "Ia merapatkan jurang inovasi yang telah lama wujud dalam pasaran pelindung matahari AS dan mencerminkan piawaian saintifik serta kawal selia moden yang dapat membantu memperluas akses pengguna Amerika kepada perlindungan UV termaju."

PARSOL® Shield (BEMT) yang telah pun diluluskan di pelbagai rantau di seluruh dunia turut membolehkan pembangunan formulasi pelindung matahari global yang memudahkan strategi produk, mengurangkan kerumitan formulasi dan mempercepat tempoh untuk memasuki pasaran.

Keupayaan memberikan perlindungan spektrum luas merupakan antara manfaat utamanya, manakala kecekapan tinggi pada kepekatan rendah menyumbang kepada profil alam sekitar yang baik serta membantu jenama memenuhi jangkaan kemampanan dan keperluan pelaporan yang sentiasa berkembang.

"Pelanggan kami telah bertahun-tahun menantikan fleksibiliti dan inovasi yang lebih luas dalam pasaran pelindung matahari AS," kata Ashley Lebbe, Naib Presiden, Global Sales Beauty & Care di dsm-firmenich. "PARSOL® Shield membuka peluang baharu untuk menghasilkan penyelesaian pelindung matahari yang bersedia untuk masa hadapan, boleh dikembangkan pada skala global serta menawarkan pengalaman pengguna yang lebih baik."

Kelulusan itu turut memperkukuh komitmen jangka panjang dsm-firmenich dalam memperjuangkan kesihatan kulit awam, termasuk menerusi kerjasama dengan pihak kawal selia, pertubuhan bukan kerajaan (NGO), penggubal undang-undang serta organisasi seperti Skin Cancer Foundation dan inisiatif Destination Healthy Skin.

PARSOL® Shield
Perlindungan Matahari, Ditakrifkan Semula.
Teroka lebih lanjut
Pengumuman Rasmi FDA

Latar Belakang dsm-firmenich
Sebagai peneraju inovasi dalam bidang pemakanan, kesihatan dan kecantikan, dsm-firmenich mencipta semula, menghasilkan dan menggabungkan nutrien penting, perisa dan wangian untuk membantu populasi dunia yang semakin bertambah menjalani kehidupan yang lebih sejahtera. Dengan rangkaian penyelesaian komprehensif yang merangkumi bahan semula jadi dan boleh diperbaharui serta keupayaan sains dan teknologi yang diiktiraf, syarikat berusaha menghasilkan sesuatu yang penting untuk kehidupan, diingini pengguna serta lebih mampan untuk manusia dan planet ini. dsm-firmenich ialah syarikat Switzerland dengan dua ibu pejabat di Kaiseraugst, Switzerland dan Maastricht, Belanda, disenaraikan di Euronext Amsterdam, serta beroperasi di hampir 60 negara dengan hasil melebihi €12 bilion. Dengan pasukan yang pelbagai terdiri daripada hampir 30,000 pekerja di seluruh dunia, kami membawa kemajuan dalam kehidupan setiap hari, di mana-mana sahaja, untuk berbilion-bilion manusia. www.dsm-firmenich.com
LinkedIn | X | Instagram | Facebook 

Untuk kenyataan pandang ke hadapan, klik di sini.

SOURCE dsm-firmenich

Modal title

Also from this source

PARSOL® Shield Approved by FDA, dsm-firmenich Setting a New Era for U.S. Sun Protection

PARSOL® Shield Approved by FDA, dsm-firmenich Setting a New Era for U.S. Sun Protection

dsm-firmenich, innovators in nutrition, health, and beauty, proudly announces the FDA approval of PARSOL® Shield (bemotrizinol, BEMT) for the U.S....

PARSOL® Shield Approved by FDA, dsm-firmenich Setting a New Era for U.S. Sun Protection

PARSOL® Shield Approved by FDA, dsm-firmenich Setting a New Era for U.S. Sun Protection

dsm-firmenich, innovators in nutrition, health, and beauty, proudly announces the FDA approval of PARSOL® Shield (bemotrizinol, BEMT) for the U.S....

More Releases From This Source

Explore

Banking & Financial Services

Banking & Financial Services

Retail

Retail

Cosmetics and Personal Care

Cosmetics and Personal Care

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

News Releases in Similar Topics

Contact PR Newswire

  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Careers
  • Accessibility Statement
  • APAC – Simplified Chinese
  • APAC
  • APAC - Traditional Chinese
  • Arabic
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
  • Vietnam

My Services

  • All New Releases
  • Platform

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
[email protected]
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
  • Accessibility
Copyright © 2026 Cision US Inc.